Ultragenyx Pharmaceutical
RARE
$56.44
Share price
-2.49%
Change (1 day)
-21.49%
Change (1 year)
Categories
Ultragenyx Pharmaceutical (RARE) - Cash on Hand
Cash on Hand as of December 2024 : A$0.97 Billion
According to Ultragenyx Pharmaceutical's latest financial reports the company has A$0.97 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Ultragenyx Pharmaceutical - Cash on Hand chart (from 2012 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | A$0.98 B | 15.76% |
| 2023-12-31 | A$0.84 B | -22.9% |
| 2022-12-31 | A$1.09 B | 7.62% |
| 2021-12-31 | A$1.02 B | -34.66% |
| 2020-12-31 | A$1.56 B | 44.86% |
| 2019-12-31 | A$1.07 B | 65.3% |
| 2018-12-31 | A$0.65 B | 117.26% |
| 2017-12-31 | A$0.30 B | -43.05% |
| 2016-12-31 | A$0.52 B | -12.08% |
| 2015-12-31 | A$0.59 B | 161.85% |
| 2014-12-31 | A$0.22 B | 282.83% |
| 2013-12-31 | A$59.84 M | -27.85% |
| 2012-12-31 | A$82.93 M | 698.88% |
| 2011-12-31 | A$10.38 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | A$1.81 B | 86.50% | 🇺🇸 USA |
 | A$0.39 B | -59.03% | 🇺🇸 USA |
 | A$0.23 B | -76.27% | 🇺🇸 USA |
 | A$0.38 B | -60.99% | 🇺🇸 USA |